Risk of Severe COVID-19 Not Raised by Immunosuppressive DMTs

Risk of Severe COVID-19 Not Raised by Immunosuppressive DMTs

301425

Risk of Severe COVID-19 Not Raised by Immunosuppressive DMTs

Exposure to multiple sclerosis (MS) disease-modifying therapies (DMTs), and particularly immunosuppressive DMTs, does not increase the risk of developing a severe form of COVID-19, or of dying from the disease, when adjusting for known risk factors, an Austrian registry-based study found. These findings add to data showing no link between the use of DMTs and any higher risk of contracting COVID-19. Moreover, an increasing number of studies, including this one, have reported no association between DMTs…

You must be logged in to read/download the full post.